Lv1
58 积分 2024-04-17 加入
Durvalumab, carboplatin, and etoposide in patients who are treatment-naive with extensive-stage small-cell lung cancer and poor performance status (NEJ045A): a single-arm phase 2 trial
2个月前
已关闭
2022年中国恶性肿瘤流行情况分析
3个月前
已完结
Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier and distribution to tumor cells in HER2+ brain metastasis model systems
3个月前
已完结
Surgical adjuvant chemotherapy in stage III Non-Small Cell Lung Cancer: Randomized controlled trial
3个月前
已完结
局限期小细胞肺癌预防性脑照射后脑转移相关危险因素分析
3个月前
已完结
[Consensus on immunotherapy for small cell lung cancer(2024 edition)]
4个月前
已完结
非小细胞肺癌新辅助治疗疗效病理评估专家共识
5个月前
已完结
First-line camrelizumab plus pemetrexed and carboplatin for advanced non-squamous non-small-cell lung cancer with brain metastases (CAP-BRAIN): final results of a multicentre, open-label, single-arm, phase 2 trial in China
6个月前
已完结
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
8个月前
已完结
皖公网安备34019202002308
